TrianglePUBLICATIONS · 14576658
Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Am Acad Dermatol
- Publication date
- 2003 Nov
- First author
- Heald P
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Heald P
- type
- Author
- name
- Mehlmauer M
- type
- Author
- name
- Martin AG
- type
- Author
- name
- Crowley CA
- type
- Author
- name
- Yocum RC
- type
- Author
- name
- Reich SD
- type
- Author
- name
- Worldwide Bexarotene Study Group
- type
- CollectiveName
Complete bibliographic record and source provenance
- authors
- name
- Heald P
- type
- Author
- name
- Mehlmauer M
- type
- Author
- name
- Martin AG
- type
- Author
- name
- Crowley CA
- type
- Author
- name
- Yocum RC
- type
- Author
- name
- Reich SD
- type
- Author
- name
- Worldwide Bexarotene Study Group
- type
- CollectiveName
- bibliography ids
- nci-bib-7777f873ec739f8801f61586
- book metadata
- content sha256
- 96115fe1cb0d84377d307a18e152504ce15e46b6771975d2764d0761f9651f50
- document type
- citation
- dois
- 10.1016/s0190-9622(03)01475-0
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:14576658
- immutable id
- pubmed:14576658@96115fe1cb0d84377d307a18e152504ce15e46b6771975d2764d0761f9651f50
- journal
- abbreviation
- J Am Acad Dermatol
- issn electronic
- Source null
- issn print
- 0190-9622
- issue
- 5
- name
- Journal of the American Academy of Dermatology
- nlm unique id
- 7907132
- pages
- 801-15
- volume
- 49
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 14576658
- provenance
- batch id
- aee154f17d1b0501fe1f
- provider
- NCBI PubMed ESummary
- record sha256
- 5c177d23e81c56d91887c3ce24fd6606687ad834c751471b1dd43bf1946c7fef
- response sha256
- 75a826407a9022d376294c7400982e19a458458cea55b2628fd3fddd75bc0f08
- retrieved at
- 2026-09-09T23:45:53.270896+00:00
- publication date
- display
- 2003 Nov
- precision
- month
- year
- 2003
- publication types
- Clinical Trial
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial.
Preserved source evidence · Not medical advice